STERIS plc (Ireland)

230.71+2.29+1.00%Vol 271.01K1Y Perf 17.64%
May 26th, 2022 16:00 DELAYED
BID209.01 ASK368.89
Open230.07 Previous Close230.71
Pre-Market- After-Market231.18
 - -  0.47 0.20%
Target Price
261.80 
Analyst Rating
Strong Buy 1.25
Potential %
13.48 
Finscreener Ranking
★★     45.09
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     45.73
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★+     50.19
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★     38.12
Price Range Ratio 52W %
62.82 
Earnings Rating
Neutral
Market Cap23.10B 
Earnings Date
11th May 2022
Alpha0.01 Standard Deviation0.06
Beta0.67 

Today's Price Range

228.89231.17

52W Range

188.10255.93

5 Year PE Ratio Range

26.6074.50

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
2.11%
1 Month
-0.26%
3 Months
-2.79%
6 Months
1.50%
1 Year
17.64%
3 Years
70.76%
5 Years
199.23%
10 Years
716.77%

TickerPriceChg.Chg.%
STE230.712.29001.00
AAPL143.783.26002.32
GOOG2 165.9249.13002.32
MSFT265.903.38001.29
XOM96.640.34000.35
WFC45.601.48003.35
JNJ179.46-0.1600-0.09
FB191.637.80004.24
GE77.012.48003.33
JPM129.442.20001.73
Financial StrengthValueIndustryS&P 500US Markets
1.20
2.00
0.31
0.45
5.90
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
44.00
10.80
19.70
13.10
5.35
RevenueValueIndustryS&P 500US Markets
4.59B
45.79
16.46
10.23
DividendsValueIndustryS&P 500US Markets
0.76
1.72
8.31
9.14
Payout ratio33.00
Earnings HistoryEstimateReportedSurprise %
Q04 20222.002.042.00
Q03 20221.952.128.72
Q02 20221.831.998.74
Q01 20221.501.7617.33
Q04 20211.801.63-9.44
Q03 20211.561.7310.90
Q02 20211.241.4819.35
Q01 20210.971.3135.05
Earnings Per EndEstimateRevision %Trend
6/2022 QR1.86-78.82Negative
9/2022 QR2.12-78.43Negative
3/2023 FY8.71--
3/2024 FY9.83--
Next Report Date-
Estimated EPS Next Report2.00
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume271.01K
Shares Outstanding100.13K
Shares Float90.79M
Trades Count11.13K
Dollar Volume62.40M
Avg. Volume437.14K
Avg. Weekly Volume418.28K
Avg. Monthly Volume437.61K
Avg. Quarterly Volume455.53K

STERIS plc (Ireland) (NYSE: STE) stock closed at 230.71 per share at the end of the most recent trading day (a 1% change compared to the prior day closing price) with a volume of 271.01K shares and market capitalization of 23.10B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 13000 people. STERIS plc (Ireland) CEO is Daniel A. Carestio.

The one-year performance of STERIS plc (Ireland) stock is 17.64%, while year-to-date (YTD) performance is -5.22%. STE stock has a five-year performance of 199.23%. Its 52-week range is between 188.1 and 255.9325, which gives STE stock a 52-week price range ratio of 62.82%

STERIS plc (Ireland) currently has a PE ratio of 94.50, a price-to-book (PB) ratio of 3.46, a price-to-sale (PS) ratio of 4.97, a price to cashflow ratio of 32.40, a PEG ratio of 2.32, a ROA of 2.76%, a ROC of 4.18% and a ROE of 4.78%. The company’s profit margin is 5.35%, its EBITDA margin is 19.70%, and its revenue ttm is $4.59 Billion , which makes it $45.79 revenue per share.

Of the last four earnings reports from STERIS plc (Ireland), there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.00 for the next earnings report. STERIS plc (Ireland)’s next earnings report date is -.

The consensus rating of Wall Street analysts for STERIS plc (Ireland) is Strong Buy (1.25), with a target price of $261.8, which is +13.48% compared to the current price. The earnings rating for STERIS plc (Ireland) stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

STERIS plc (Ireland) has a dividend yield of 0.76% with a dividend per share of $1.72 and a payout ratio of 33.00%.

STERIS plc (Ireland) has a Buy technical analysis rating based on Technical Indicators (ADX : 9.15, ATR14 : 6.04, CCI20 : 113.15, Chaikin Money Flow : 0.11, MACD : -1.63, Money Flow Index : 70.54, ROC : 7.12, RSI : 54.29, STOCH (14,3) : 97.92, STOCH RSI : 1.00, UO : 64.76, Williams %R : -2.08), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of STERIS plc (Ireland) in the last 12-months were: Andrew Xilas (Option Excercise at a value of $0), Cary L Majors (Sold 12 950 shares of value $2 857 217 ), Cynthia L. Feldmann (Option Excercise at a value of $135 017), Cynthia L. Feldmann (Sold 1 891 shares of value $442 683 ), J. Adam Zangerle (Option Excercise at a value of $543 840), J. Adam Zangerle (Sold 8 000 shares of value $2 043 876 ), Jacqueline B. Kosecoff (Option Excercise at a value of $104 134), Jacqueline B. Kosecoff (Sold 3 218 shares of value $756 874 ), Karen L. Burton (Option Excercise at a value of $489 552), Karen L. Burton (Sold 6 600 shares of value $1 588 786 ), Michael J. Tokich (Option Excercise at a value of $3 451 200), Michael J. Tokich (Sold 58 000 shares of value $13 900 000 ), Renato Tamaro (Option Excercise at a value of $147 729), Renato Tamaro (Sold 1 449 shares of value $309 550 ), Richard C. Breeden (Option Excercise at a value of $98 655)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
1 (25.00 %)
1 (20.00 %)
1 (20.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.25
Strong Buy
1.20
Strong Buy
1.20

STERIS plc (Ireland)

Steris PLC is a medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Its operating segment includes Healthcare, Applied Sterilization Technologies, and Life Sciences. The company generates maximum revenue from Healthcare segment.

CEO: Daniel A. Carestio

Telephone: +1 440 354-2600

Address: 5960 Heisley Road, Mentor 44060, OH, US

Number of employees: 13 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

61%39%

Bearish Bullish

60%40%

Bearish Bullish

62%38%

TipRanks News for STE

Thu, 12 May 2022 10:15 GMT Analysts Offer Insights on Healthcare Companies: Biolinerx (BLRX), Steris (STE) and TRACON Pharmaceuticals (TCON)

- TipRanks. All rights reserved.

Tue, 12 Apr 2022 09:25 GMT Needham Believes Steris (STE) Still Has Room to Grow

- TipRanks. All rights reserved.

Wed, 16 Feb 2022 09:52 GMT Steris Updates 1 Key Risk Factor

- TipRanks. All rights reserved.

Wed, 09 Feb 2022 05:35 GMT Analysts Offer Insights on Healthcare Companies: Steris (STE) and Enanta Pharmaceuticals (ENTA)

- TipRanks. All rights reserved.

Wed, 26 Jan 2022 09:45 GMT Inside Evoqua Water Technologies Newly Added Risk Factors

- TipRanks. All rights reserved.

News

Stocktwits